BRAIN CANCER

Latest News

MB-108 Gains FDA Orphan Drug Status for Malignant Glioma Treatment
MB-108 Gains FDA Orphan Drug Status for Malignant Glioma Treatment

November 8th 2024

MB-108 shows activity and is well tolerated in recurrent glioblastoma, with preclinical data supporting its combination with MB-101 CAR T-cell therapy for improved outcomes.

FDA Grants Priority Review for TLX101-CDx PET Imaging Agent in Glioma
FDA Grants Priority Review for TLX101-CDx PET Imaging Agent in Glioma

October 24th 2024

FDA Approves Companion Diagnostic for Vorasidenib in IDH-Mutant Glioma
FDA Approves Companion Diagnostic for Vorasidenib in IDH-Mutant Glioma

October 21st 2024

LP-184 Earns FDA Fast Track Designation in Glioblastoma
LP-184 Earns FDA Fast Track Designation in Glioblastoma

October 17th 2024

The Promise of IL-21 Engineered NK Cells in Glioblastoma Treatment
The Promise of IL-21 Engineered NK Cells in Glioblastoma Treatment

August 30th 2024

Latest CME Events & Activities

Community Practice Connections™: 5th Annual Precision Medicine Symposium – An Illustrated Tumor Board

View More

Community Oncology Connections™: Controversies and Conversations About HER2-Expressing Breast Cancer… Advances in Management from HER2-Low to Positive Disease

View More

42nd Annual Miami Breast Cancer Conference®

March 6 - 9, 2025

Register Now!

The Evolving Tool Box in Advanced HR+/HER2– Breast Cancer: What You Need to Know About Next-Generation SERDs, PI3K/AKT, ADCs, CDK4/6 and Beyond…

View More

Coffee Talk™: Navigating the Impact of HER2/3, TROP2, and PARP from Early Stage to Advanced Breast Cancer Care

View More

Fighting Disparities and Saving Lives: An Exploration of Challenges and Solutions in Cancer Care

View More

<1
...
1314151617